1 / 14

Impact of an antidepressant adherence program in a managed care organization

Kara Zivin Bambauer, PhD Stephen Soumerai, ScD Alyce Adams, PhD Fang Zhang, PhD. Rick Weisblatt, PhD Neil Minkoff, MD Andrea Grande, RPh Dennis Ross-Degnan, ScD. Impact of an antidepressant adherence program in a managed care organization.

Download Presentation

Impact of an antidepressant adherence program in a managed care organization

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Kara Zivin Bambauer, PhD Stephen Soumerai, ScD Alyce Adams, PhD Fang Zhang, PhD Rick Weisblatt, PhD Neil Minkoff, MD Andrea Grande, RPh Dennis Ross-Degnan, ScD Impact of an antidepressant adherence program in a managed care organization Harvard Pilgrim Health Care and Harvard Medical School

  2. Background • The burden of depression is substantial • Effective medications are available to treat depression • Non-adherence to antidepressants remains a substantial problem • Harvard Pilgrim Health Care (HPHC) sought to improve quality of care for depression using available electronic data

  3. Objectives • To evaluate the effectiveness of providing faxed feedback to physicians regarding patient refill behavior • Does the proportion of patients who are potentially non-adherent to treatment decrease after the policy? • Does the proportion of days within a treatment episode without antidepressant coverage decrease after the policy?

  4. Content of Fax • Introduction: This is a clinical reminder to assist physicians who are treating patients for Major Depressive Disorder (MDD) • Explanation: There are 3 quality of care measures for depression treatment • Summary: information on antidepressant compliance • Symptoms usually remit in 4-6 weeks • Therapy should be continued for 6 months • Only 40% of patients of patients adhere to antidepressant treatment • Closing: Your patient (insert name) has gone more than 10 days without antidepressant treatment (medication name, dose, quantity)

  5. Antidepressant Compliance Program (ACP) Definitions • Adherent: antidepressant prescription refilled within 10 days of an expected refill • If not, a fax is sent to the prescribing physician • Potentially non-adherent: antidepressant prescription refilled more than 10 days and less than 30 days after an expected refill • Failure: antidepressant prescription not refilled within 30 days of an expected refill

  6. Assumptions Underlying ACP • The prescribing physician receives the fax • The physician makes contact with the patient • A physician-patient conversation occurs that effectively deals with the reasons for patient non-adherence • The patient subsequently refills the antidepressant prescription in a timely manner

  7. Inclusion Criteria • All HPHC members were eligible • All types of providers were included • Each patient needed to be enrolled for 6 months before and 6 months after first antidepressant use • Patients were included who used a select subset of antidepressants usually indicated for treatment of depression • New users of antidepressants (no use in previous 100 days) • First episode of antidepressant treatment for each person • Age ≥ 18

  8. Timeline

  9. Methods • Interrupted time-series (ITS) analysis using SAS PROC AUTOREG • Used to evaluate rates of change in adherence due to the ACP • Look at slope and level changes • ITS is one of the strongest quasi-experimental designs for studying policy changes

  10. Characteristics of Study Participants (N=13,128) • Mean age (sd): 42 (11) • Gender: 69% female • Policy Variables • Adherent: 18% • Potentially non-adherent: 29% • Failure: 53% • No significant differences in pre-policy and post-policy patients

  11. Percent of Non-Adherent Patients Who Proceed to Adherence Failure Percent Adherence Failures Pre-ACP period First year of ACP Phase-in period

  12. Mean Percent of Treatment Days Not Covered Percent Treatment Days Uncovered Pre-ACP period First year of ACP Phase-in period

  13. Limitations and Implications • Electronic reminder systems, while popular, may not improve patient adherence • Success of such interventions requires a complex chain of events to occur • We cannot determine from electronic data whether communication between physicians and patients addresses reasons for patient non-adherence • Stand alone interventions targeting adherence are not successful

  14. Conclusions • The ACP was not successful at increasing antidepressant adherence rates in HPHC members • Additional research should re-examine assumptions underlying the ACP to identify ways to improve future antidepressant adherence interventions • Effectiveness of electronic interventions should be carefully evaluated before widespread implementation

More Related